One of the most challenging approaches is to identify T and B cell epitopes that are correlating with optimal CD4+ helper, CD8+ cytotoxic T cell and B cell responses and may be associated with clinically mild COVID-19 courses or even constitute potential vaccine candidates [3,4,5]. Here, CD4 is linked to COVID-19.